The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
A Review and Update on Cholangiocarcinoma
Abstract
Cholangiocarcinoma is a malignant neoplasm arising from the biliary epithelium that was first described by Durand-Fardel in 1840. Today, it continues to defy diagnosis and treatment. It is difficult to diagnose in part because of its relative rarity, and because it is clinically silent until it becomes advanced disease with obstructive symptoms. The worldwide incidence of cholangiocarcinoma has risen over the past three decades. There is marked geographic variability in the prevalence of this disease, due in large part to regional environmental risk factors. Surgical resection remains the only curative treatment, and high priorities are improving diagnostic methods, and clinical staging for resection once the disease is suspected. A recent trend towards aggressive surgical management has improved outcomes. Chemotherapy, palliative stenting, and radiation are reserved for patients who are not resectable, those with recurrence after surgery, and those who decline surgical intervention. Recent trials using combination systemic chemotherapy and neoadjuvant chemoradiation are promising, but require further study. Over the past five years, several important studies have yielded new insights into the molecular mechanisms of cholangiocarcinoma tumorigenesis. In this review we discuss epidemiology, etiologic factors, molecular pathogenesis, diagnosis, staging, and treatment of cholangiocarcinoma. Particular focus is on recent studies into the cellular and molecular pathogenesis of the disease, recent chemotherapy trials, and newer methods of staging and screening for this devastating malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AJCC Cancer Staging Manual. 6th ed
Greene, F., Page, D., Id, F., Fritz, J., Balch, C., & Haller, D. (2002) · Cited by 2,324
Cholangiocarcinoma: A Spectrum of Intrahepatic, Perihilar, and Distal Tumors
Nakeeb, A., Pitt, H. A., Sohn, T. A., Coleman, J., Abrams, R. A., Piantadosi, S., Hruban, R. H., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00005 · Cited by 1,187
Endosonography-guided fine-needle aspiration biopsy: Diagnostic accuracy and complication assessment
Wiersema, M., Vilmann, P., Giovannini, M., Chang, K., & Wiersema, L. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70164-1 · Cited by 1,131
Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States
Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.25087 · Cited by 1,010
Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis
Klatskin, G. (1965) · The American Journal of Medicine · doi:10.1016/0002-9343(65)90178-6 · Cited by 820
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg-Gertzén, H., Wallerstedt, S., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 819
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.
Bismuth, H., & Corlette, M. B. (1975) · PubMed · Cited by 751
Jaiswal, M., LaRusso, N. F., Burgart, L. J., & Gores, G. J. (2000) · PubMed · Cited by 653
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document
Khan, S. A., Davidson, B. R., Goldin, R., Pereira, S. P., Rosenberg, W. M. C., Taylor-Robinson, S. D., Thillainayagam, A. V., Thomas, H. C., Thursz, M. R., & Wasan, H. (2002) · Gut · doi:10.1136/gut.51.suppl_6.vi1 · Cited by 648
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
Khan, S. A., Taylor-Robinson, S. D., Toledano, M. B., Beck, A., Elliott, P., & Thomas, H. C. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00297-0 · Cited by 570
Cited by
Khan, S. A., Thomas, H. C., Davidson, B. R., & Taylor-Robinson, S. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67530-7 · Cited by 1,042
Liver Fluke Induces Cholangiocarcinoma
Sripa, B., Kaewkes, S., Sithithaworn, P., Mairiang, E., Laha, T., Smout, M., Pairojkul, C., Bhudhisawasdi, V., Tesana, S., Thinkamrop, B., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040201 · Cited by 775
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment†
Blechacz, B., & Gores, G. J. (2008) · Hepatology · doi:10.1002/hep.22310 · Cited by 681
Epidemiology of cholangiocarcinoma: An update focusing on risk factors
Shin, H., Oh, J., Masuyer, E., Curado, M., Bouvard, V., Fang, Y., Wiangnon, S., Sripa, B., & Hong, S. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01458.x · Cited by 454
Ringe, K. I., Husarik, D. B., Sirlin, C. B., & Merkle, E. M. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4392 · Cited by 388
Metadata
- Authors
- Olnes, M. J., & Erlich, R.
- Venue
- Oncology
- Publisher
- S. Karger AG
- Published
- 2004
- Volume
- 66
- Issue
- 3
- Pages
- 167-179
- ISSN
- 0030-2414 (ISSN-L)
- 1423-0232
- OpenAlex
- W1993180801
- Cited by
- 266
- References
- 70
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Review and Update on Cholangiocarcinoma. https://app.cochat.ai/papers/10.1159/000077991
- The paper
- Olnes, M. J., & Erlich, R. (2004). A Review and Update on Cholangiocarcinoma. Oncology. https://doi.org/10.1159/000077991
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.